IL6 and neoplasm: Meanwhile, IL-17F was shown to directly inhibit the vascular endothelial cells and decrease the expression of angiogenesis factors including IL-6, IL-8, and VEGF, thus inhibiting tumor angiogenesis and tumor growth (138).